Does this LIXT Form 3 show any insider share transactions?

No insider share transactions are shown in this Form 3 data. All transaction-related counts, including buy, sell, acquire, dispose, and derivative transaction totals, are recorded as zero, indicating no reported trades in the period covered by this filing data.

LIXTE director reports no insider trades

Q: Who is the reporting person in LIXT's Form 3 filing?

The reporting person is Stuart D Porter, identified as a director of LIXTE Biotechnology Holdings, Inc. The data lists him as a director, with no officer role, and does not indicate ten percent ownership status.

LIXTE Biotechnology Holdings, Inc. filed a regulatory ownership report identifying Stuart D Porter as a director.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

LIXTE Biotechnology Holdings, Inc. filed a regulatory ownership report identifying Stuart D Porter as a director. The provided data shows no reported transactions, no derivative positions, and no share movements, with all transaction counts and share amounts listed as zero.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

Who is the reporting person in LIXT's Form 3 filing?

The reporting person is Stuart D Porter, identified as a director of LIXTE Biotechnology Holdings, Inc. The data lists him as a director, with no officer role, and does not indicate ten percent ownership status.

Are there any derivative securities reported in LIXT's Form 3?

No derivative securities are reported in this Form 3. The derivativeSummary section is empty and the derivativeTransactionCount is zero, indicating no options, warrants, or other derivative positions disclosed in the provided dataset for this reporting person.

Does the LIXT Form 3 indicate any gifts or tax-withholding transactions?

The Form 3 data indicates no gifts or tax-withholding transactions. Gift and tax-withholding counts and related share amounts are all zero, suggesting there were no such non-market transfers or withholdings reported for the period covered by this filing.

What does the transaction summary show in LIXT's Form 3?

The transaction summary shows zero activity across all categories. Buy, sell, exercise, gift, tax-withholding, restructuring, and derivative transaction counts and share amounts are all zero, and the net buy/sell direction is listed as neutral in the provided data.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 06/01/2026 - 04:00 PM

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Porter Stuart D

(Last)

(First)

(Middle)

433 PLAZA REAL, SUITE 275

(Street)

BOCA RATON

FLORIDA

33432

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
05/29/2026

3. Issuer Name and Ticker or Trading Symbol
LIXTE BIOTECHNOLOGY HOLDINGS, INC. [ LIXT ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)

Explanation of Responses:

No securities are beneficially owned.

	/s/ Stuart D. Porter	06/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR